首頁 > 市場調查報告書 > 製藥

基因治療學和RNAi 以基因為基之藥物開發

市場調查報告書

商品編碼

1561058

CRISPR 技術市場規模、佔有率、成長分析、按產品類型、按應用、按地區 - 產業預測，2024-2031 年

CRISPR Technology Market Size, Share, Growth Analysis, By Product Type (Products, Services), By Application (Biomedical, Industrial), By Application (Pharma & Biopharma Companies, Biotechnology Companies), By Region - Industry Forecast 2024-2031

出版日期: 2024年09月22日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2022年CRISPR技術的全球市場規模估值為30億美元，從2023年的35億美元成長到2031年的118.6億美元，預計在預測期內（2024-2031年）複合年成長率為16.50。％。

全球CRISPR技術市場是生物技術領域快速發展且前景看好的領域。 CRISPR 代表成簇規則間隔短回文重複序列，是一種革命性的基因編輯工具，可以對生物體的 DNA 進行精確的改變。這項創新技術因其解決遺傳疾病、推進治療方法開發和改變農業實踐的潛力而引起了人們的極大興趣。 CRISPR 市場經歷了顯著成長，預計在不久的將來將繼續擴大。有幾個因素促成了這種成長，包括對個人化醫療的需求不斷增加、基因治療的進步以及遺傳疾病盛行率的增加。 CRISPR技術與藥物發現、市場開拓和診斷工具創建的整合正在進一步加速市場擴張。此外，在工業生物技術中，CRISPR 被用於生物工程和生物製造，以創造新的酵素、生質燃料和特殊化學品，作為傳統製造方法的永續替代品。總體而言，CRISPR 技術市場正在迅速發展，並有潛力徹底改變醫療保健、農業和工業生物技術等各個領域。其應用具有增強人類健康、改善食品生產和推動永續製造方法的潛力。隨著研究和開發的進展，解決倫理和監管問題對於確保 CRISPR 技術的負責任和有益的使用至關重要。

市場概況
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲國家地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 其他亞太地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲 (MEA)
- 海灣合作理事會國家
- 南非
- 其他中東/非洲地區

競爭格局

前5名企業對比
主要企業市場定位（2023年）
主要市場參與者所採取的策略
近期市集活動
主要企業市場佔有率（2023年）

主要企業簡介

Thermo Fisher Scientific Inc.（US）
Merck KGaA（Germany）
Integrated DNA Technologies（Danaher Corporation）（US）
Agilent Technologies Inc.（US）
Genscript Biotech Corp（China）
New England Biolabs Inc.（US）
Cellecta Limited（US）
GeneCopoeia Inc.（US）
Origene Technologies Inc.（US）
Editas Medicine, Inc.（US）
CRISPR Therapeutics AG（Switzerland）
Intellia Therapeutics, Inc.（US）
Illumina, Inc.（US）
Base Genomics Inc.（US）
Synthego Corporation（US）
Prime Medicine, Inc.（US）
Arbor Biotechnologies（US）
Excision BioTherapeutics, Inc.（US）
Mammoth Biosciences, Inc.（US）

簡介目錄

Product Code: SQMIG35H2108

Global CRISPR Technology Market size was valued at USD 3.0 billion in 2022 and is poised to grow from USD 3.50 billion in 2023 to USD 11.86 billion by 2031, growing at a CAGR of 16.50% during the forecast period (2024-2031).

The global CRISPR technology market is a rapidly developing and promising area within biotechnology. CRISPR, which stands for Clustered Regularly Interspaced Short Palindromic Repeats, represents a revolutionary gene-editing tool that enables precise alterations to the DNA of living organisms. This innovative technology has captured significant interest due to its potential to address genetic disorders, drive advancements in therapeutic development, and transform agricultural practices. The CRISPR market has experienced notable growth and is projected to continue expanding in the near future. Several factors contribute to this growth, including the rising demand for personalized medicine, progress in gene therapy, and the increasing prevalence of genetic disorders. The integration of CRISPR technology into drug discovery, development, and diagnostic tool creation has further accelerated market expansion. Additionally, the industrial biotechnology sector is utilizing CRISPR for bioengineering and bio-manufacturing, enabling the creation of novel enzymes, biofuels, and specialty chemicals that offer sustainable alternatives to conventional manufacturing methods. Overall, the CRISPR technology market is evolving rapidly with the potential to revolutionize various fields, including healthcare, agriculture, and industrial biotechnology. Its applications hold promise for enhancing human health, improving food production, and advancing sustainable manufacturing practices. As research and development continue to progress, addressing ethical and regulatory concerns will be essential to ensure the responsible and beneficial use of CRISPR technology moving forward.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global CRISPR Technology market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global CRISPR Technology Market Segmental Analysis

Global CRISPR Technology Market is segmented by Product Type, Application, and region. Based on Product Type, the market is segmented into Products [CRISPR Libraries, CRISPR Kits & Enzymes, Other Products], Services [Cell Line Engineering, gRNA Design & Vector Consultation, Screening Services, Other Services]. Based on Application, the market is segmented into Biomedical, Industrial, Agricultural, and Other Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Drivers of the Global CRISPR Technology Market

Governments worldwide have significantly ramped up their funding and investment in CRISPR technology, creating a supportive environment for research and development. This increased financial backing has facilitated groundbreaking discoveries and accelerated advancements in the field, fostering a dynamic market for CRISPR innovations. As a result, the enhanced investment in CRISPR technology has led to a more vibrant and promising sector, driving progress and expanding opportunities within biotechnology. This support from government bodies is crucial for advancing research efforts and bringing transformative CRISPR-based solutions to fruition.

Restraints in the Global CRISPR Technology Market

The gene editing field faces significant technical challenges associated with CRISPR technology. Despite its considerable potential, several hurdles impede its broader application, including the complexity of achieving precise genome modifications, managing off-target effects, and ensuring effective delivery mechanisms. Addressing these technical issues is crucial for CRISPR technology to fulfill its transformative potential across various industries. Overcoming these obstacles will be key to unlocking the full benefits of CRISPR and advancing its use in a wide range of applications.

Market Trends of the Global CRISPR Technology Market

A notable trend in the CRISPR technology market is the growing integration of CRISPR in drug discovery and development. Pharmaceutical and biotechnology companies are increasingly leveraging CRISPR to streamline the drug discovery process, enhance target identification and validation, and improve both preclinical and clinical studies. CRISPR-based screening platforms facilitate more efficient identification and validation of drug targets, which contributes to the development of more effective therapies. Furthermore, CRISPR enables the creation of advanced disease models and organoids, aiding in the study of disease mechanisms and the evaluation of potential drug candidates. In addition to its impact on drug discovery, CRISPR technology is also making strides in agriculture and food production, as well as in the development of CRISPR-based diagnostics. The emphasis on ethical and regulatory considerations is also growing, reflecting a broader awareness of the implications of CRISPR technology. These trends underscore the expanding potential of CRISPR across multiple industries, highlighting its transformative capabilities and the ongoing evolution of its applications.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Ecosystem of the Market
Trade Analysis
Supply chain Analysis
Case study Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition

CRISPR Technology Market by Product Type

Market Overview
Products
- CRISPR Libraries
- CRISPR Kits & Enzymes
- Other Products
Services
- Cell Line Engineering
- gRNA Design & Vector Consultation
- Screening Services
- Other Services

CRISPR Technology Market by Application

Market Overview
Biomedical
Industrial
Agricultural
Other Applications

CRISPR Technology Market by End-User

Market Overview
Pharma & Biopharma Companies
Biotechnology Companies
Academic & Research Institutes
Contract Research Organizations

CRISPR Technology Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Integrated DNA Technologies (Danaher Corporation) (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genscript Biotech Corp (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
New England Biolabs Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cellecta Limited (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GeneCopoeia Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Origene Technologies Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Editas Medicine, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
CRISPR Therapeutics AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Intellia Therapeutics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Base Genomics Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synthego Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Prime Medicine, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Arbor Biotechnologies (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Excision BioTherapeutics, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Mammoth Biosciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments